[1]刘晶 唐威 张洁 程瑞 李兴.血清CTRP5、脂联素与颈动脉粥样硬化的关系[J].国际内分泌代谢杂志,2022,42(01):21-26.[doi:10.3760/cma.j.cn121383-20201104-11008]
　Liu Jing,Tang Wei,Zhang Jie,et al.Relationship between serum CTRP5, adiponectin and carotid atherosclerosis in type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2022,42(01):21-26.[doi:10.3760/cma.j.cn121383-20201104-11008]
点击复制

血清CTRP5、脂联素与颈动脉粥样硬化的关系()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
42
期数:
2022年01期
页码:
21-26
栏目:
论著
出版日期:
2022-01-20

文章信息/Info

Title:
Relationship between serum CTRP5, adiponectin and carotid atherosclerosis in type 2 diabetes mellitus
作者:
刘晶 唐威 张洁 程瑞 李兴
山西医科大学第二医院内分泌科,太原 030009
Author(s):
Liu Jing;  Tang Wei;  Zhang Jie;  Cheng Rui;  Li Xing.
Department of Endocrinology, the Second Hospital of Shanxi Medical University, Taiyuan 030009, China
关键词:
C1q/肿瘤坏死因子相关蛋白5;  脂联素;  2型糖尿病;  糖尿病大血管病变
Keywords:
C1q/tumor necrosis factor related protein 5;  Adiponectin;  Type 2 diabetes mellitus;  Diabetic macroangiopathy
DOI:
10.3760/cma.j.cn121383-20201104-11008
摘要:
目的 探讨2型糖尿病(T2DM)血清C1q/肿瘤坏死因子相关蛋白5(CTRP5)、脂联素(APN)的水平与颈动脉粥样硬化(CAS)的关系。方法 采用病例对照研究,纳入2019年8月至2019年11月就诊于山西医科大学第二医院的患者共125例,其中健康对照组45例,T2DM无CAS患者(T2DM组)40例及T2DM合并CAS患者(T2DM+CAS组)40例。采用酶联免疫吸附法(ELISA)检测血清CTRP5、APN水平。结果 T2DM患者血清CTRP5较对照组升高(P<0.05),且T2DM+CAS组进一步升高(P<0.05)。血清APN在T2DM患者中减低(P<0.05),但在T2DM组与T2DM+CAS组间无显著差异(P>0.05); CTRP5为T2DM合并CAS的独立危险因素,可作为T2DM合并CAS的筛查指标; 血清CTRP5与APN、高密度脂蛋白-胆固醇(HDL-C)、收缩压、糖化血红蛋白A1c(HbA1c)、体重指数(BMI)和空腹胰岛素(FINS)相关(P均<0.01)。结论 血清CTRP5水平与糖尿病大血管病变相关,可作为T2DM是否合并CAS的预测因子。
Abstract:
Objective To measure the level of serum C1q/tumor necrosis factor related protein 5(CTRP5)and adiponectin(APN)in type 2 diabetes mellitus(T2DM)with carotid atherosclerosis(CAS), and to investigate the relationship between CTRP5, APN and CAS.Methods In this case control study we enrolled 125 subjects who were diagnosed in the Second Hospital of Shanxi Medical University between August 2019 and November 2019, including 45 healthy control subjects(control group), 40 T2DM without CAS(T2DM group), and 40 T2DM with CAS(T2DM+CAS group). Serum CTRP5 and APN were determined by ELISA.Results Serum CTRP5 level in T2DM patients was higher than that in the control group(P<0.05), and further increased in T2DM+CAS group(P<0.05). Serum APN level was significantly reduced in T2DM patients(P<0.05), but there was no significant difference between T2DM group and T2DM+CAS group(P>0.05). Serum CTRP5 level was an independent risk factor for T2DM with CAS, which might be used as a screening index for T2DM combined with CAS. Serum CTRP5 level was correlated with APN, HDL-C, SBP, HbA1c, BMI and FINS(P<0.01).Conclusion Serum CTRP5 level is associated with diabetic macroangiopathy and may serve as an independent predictor of T2DM combined with CAS.

参考文献/References:

[1] Narayan KM.Type 2 diabetes:Why we are winning the battle but losing the war? 2015 kelly west award lecture[J].Diabetes Care,2016,39(5):653-663.DOI:10.2337/dc16-0205.
[2] Brohall G,Odén A,Fagerberg B.Carotid artery intima-media thickness in patients with type 2 diabetes mellitus and impaired glucose tolerance:a systematic review[J].Diabet Med,2006,23(6):609-616.DOI:10.1111/j.1464-5491.2005.01725.x.
[3] Satish M,Saxena SK,Agrawal DK.Adipokine dysregulation and insulin resistance with atherosclerotic vascular disease:metabolic syndrome or independent sequelae?[J].J Cardiovasc Transl Res,2019,12(5):415-424.DOI:10.1007/s12265-019-09879-0.
[4] 常海瑶,刘晶,吴文昊,等.血管生成素样蛋白6、瘦素与糖尿病肾病的关系[J].中华内分泌代谢杂志,2020,40(5):289-293.DOI:10.3760/cma.j.cn121383-20200208-02009.
[5] Wong GW,Krawczyk SA,Kitidis-Mitrokostas C,et al.Molecular,biochemical and functional characterizations of C1q/TNF family members:adipose-tissue-selective expression patterns,regulation by PPAR-gamma agonist,cysteine-mediated oligomerizations,combinatorial associations and metabolic functions[J].Biochem J,2008,416(2):161-177.DOI:10.1042/BJ20081240.
[6] Schäffler A,Buechler C.CTRP family:linking immunity to metabolism[J].Trends Endocrinol Metab,2012,23(4):194-204.DOI:10.1016/j.tem.2011.12.003.
[7] Lei X,Rodriguez S,Petersen PS,et al.Loss of CTRP5 improves insulin action and hepatic steatosis[J].Am J Physiol Endocrinol Metab,2016,310(11):E1036-1052.DOI:10.1152/ajpendo.00010.2016.
[8] Li C,Chen JW,Liu ZH,et al.CTRP5 promotes transcytosis and oxidative modification of low-density lipoprotein and the development of atherosclerosis[J].Atherosclerosis,2018,278:197-209.DOI:10.1016/j.atherosclerosis.2018.09.037.
[9] Shen Y,Li C,Zhang RY,et al.Association of increased serum CTRP5 levels with in-stent restenosis after coronary drug-eluting stent implantation:CTRP5 promoting inflammation,migration and proliferation in vascular smooth muscle cells[J].Int J Cardiol,2017,228:129-136.DOI:10.1016/j.ijcard.2016.11.034.
[10] Chambless LE,Folsom AR,Clegg LX,et al.Carotid wall thickness is predictive of incident clinical stroke:the Atherosclerosis Risk in Communities(ARIC)study[J].Am J Epidemiol,2000,151(5):478-487.DOI:10.1093/oxfordjournals.aje.a010233.
[11] Wolf RM,Steele KE,Peterson LA,et al.Lower circulating C1q/TNF-related protein-3(CTRP3)levels are associated with obesity:a cross-sectional study[J].PLoS One,2015,10(7):e0133955.DOI:10.1371/journal.pone.0133955.
[12] Lei X,Seldin MM,Little HC,et al.C1q/TNF-related protein 6(CTRP6)links obesity to adipose tissue inflammation and insulin resistance[J].J Biol Chem,2017,292(36):14836-14850.DOI:10.1074/jbc.M116.766808.
[13] Wolf RM,Steele KE,Peterson LA,et al.C1q/TNF-related protein-9(CTRP9)levels are associated with obesity and decrease following weight loss surgery[J].J Clin Endocrinol Metab,2016,101(5):2211-2217.DOI:10.1210/jc.2016-1027.
[14] Petersen PS,Lei X,Wolf RM,et al.CTRP7 deletion attenuates obesity-linked glucose intolerance,adipose tissue inflammation,and hepatic stress[J].Am J Physiol Endocrinol Metab,2017,312(4):E309-E325.DOI:10.1152/ajpendo.00344.2016.
[15] Wang H,Wang R,Du D,et al.Serum levels of C1q/TNF-related protein-1(CTRP-1)are closely associated with coronary artery disease[J].BMC Cardiovasc Disord,2016,16:92.DOI:10.1186/s12872-016-0266-7.
[16] Zietz B,Herfarth H,Paul G,et al.Adiponectin represents an independent cardiovascular risk factor predicting serum HDL-cholesterol levels in type 2 diabetes[J].FEBS Lett,2003,545(2-3):103-104.DOI:10.1016/s0014-5793(03)00568-4.
[17] Nishikawa T,Edelstein D,Du XL,et al.Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage[J].Nature,2000,404(6779):787-790.DOI:10.1038/35008121.
[18] Park SY,Choi JH,Ryu HS,et al.C1q tumor necrosis factor alpha-related protein isoform 5 is increased in mitochondrial DNA-depleted myocytes and activates AMP-activated protein kinase[J].J Biol Chem,2009,284(41):27780-27789.DOI:10.1074/jbc.M109.005611.
[19] Yang WM,Lee W.CTRP5 ameliorates palmitate-induced apoptosis and insulin resistance through activation of AMPK and fatty acid oxidation[J].Biochem Biophys Res Commun,2014,452(3):715-721.DOI:10.1016/j.bbrc.2014.08.145.
[20] Schmid A,Kopp A,Aslanidis C,et al.Regulation and function of C1Q/TNF-related protein-5(CTRP-5)in the context of adipocyte biology[J].Exp Clin Endocrinol Diabetes,2013,121(5):310-317.DOI:10.1055/s-0032-1333299.

相似文献/References:

[1]张珊,张洁,傅力.2型糖尿病患者血清脂联素与肝脏脂肪 含量的相关性研究[J].国际内分泌代谢杂志,2017,37(03):155.[doi:10.3760/cma.j.issn.1673-4157.2017.03.003]
　Zhang Shan*,Zhang Jie,Fu Li..The correlation analysis between serum adiponectin level and liver fat content in patients with type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2017,37(01):155.[doi:10.3760/cma.j.issn.1673-4157.2017.03.003]
[2]范琳玲,叶红英,王熠.APPL1在糖尿病及其并发症中的作用[J].国际内分泌代谢杂志,2017,37(03):199.[doi:10.3760/cma.j.issn.1673-4157.2017.03.015]
　Fan Linling,Ye Hongying,Wang Yi..Role of APPL1 in diabetes mellitus and its complications[J].International Journal of Endocrinology and Metabolism,2017,37(01):199.[doi:10.3760/cma.j.issn.1673-4157.2017.03.015]

备注/Memo

备注/Memo:
通信作者:李兴,Email: 13503504180@163.com
更新日期/Last Update: 2022-01-20